SERRA, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.995
EU - Europa 1.272
AS - Asia 915
AF - Africa 58
SA - Sud America 12
OC - Oceania 11
Totale 4.263
Nazione #
US - Stati Uniti d'America 1.970
CN - Cina 527
IT - Italia 471
SE - Svezia 140
IE - Irlanda 134
KR - Corea 123
SG - Singapore 110
AT - Austria 96
UA - Ucraina 87
FR - Francia 85
DE - Germania 69
FI - Finlandia 54
SN - Senegal 53
GB - Regno Unito 34
IN - India 32
VN - Vietnam 29
JP - Giappone 28
CA - Canada 24
BE - Belgio 18
PL - Polonia 17
HK - Hong Kong 16
NL - Olanda 13
TW - Taiwan 13
AU - Australia 10
CZ - Repubblica Ceca 10
ES - Italia 10
IR - Iran 10
BY - Bielorussia 8
CH - Svizzera 8
ID - Indonesia 8
MO - Macao, regione amministrativa speciale della Cina 6
AR - Argentina 5
EG - Egitto 5
BR - Brasile 4
DK - Danimarca 4
UZ - Uzbekistan 4
SK - Slovacchia (Repubblica Slovacca) 3
GR - Grecia 2
HU - Ungheria 2
PH - Filippine 2
TH - Thailandia 2
UY - Uruguay 2
BG - Bulgaria 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 4.263
Città #
Chandler 335
Beijing 233
Torino 192
Ashburn 138
Dublin 132
Vienna 95
Ann Arbor 90
Fairfield 88
Houston 80
Singapore 77
Nyköping 76
Villeurbanne 66
Wilmington 61
Dearborn 50
Guangzhou 47
Centro 45
Princeton 45
Medford 42
Woodbridge 41
Cambridge 39
Fremont 38
New York 38
Redwood City 38
Jacksonville 35
Milan 35
Shanghai 35
Seattle 32
Pisa 26
Nanjing 25
Dong Ket 21
San Mateo 21
Boston 20
Boardman 17
Turin 17
Brussels 15
Warsaw 15
Santa Clara 12
Bologna 11
Düsseldorf 10
Garessio 9
Taipei 9
Toronto 9
Jakarta 8
Ottawa 8
Chengdu 6
Columbus 6
Fuzhou 6
Hamburg 6
Hangzhou 6
Los Angeles 6
Nanchang 6
Norwalk 6
Shenyang 6
Tianjin 6
Tokyo 6
Wuhan 6
Des Moines 5
Hefei 5
Kunming 5
Munich 5
Phoenix 5
Wenzhou 5
Xian 5
Ancona 4
Birmingham 4
Brisbane 4
Delhi 4
Falls Church 4
Geneve 4
Genova 4
Hong Kong 4
Jinan 4
Leiden 4
Paris 4
Stockholm 4
Washington 4
Yichang 4
Austin 3
Barcelona 3
Berbenno Di Valtellina 3
Bratislava 3
Brescia 3
Brookline 3
Central District 3
Changsha 3
Chennai 3
Chicago 3
Heidelberg 3
Higashiikebukuro 3
Karaj 3
La Jolla 3
Marche 3
Mountain View 3
Nagoya 3
Prague 3
San Diego 3
San Jose 3
Sydney 3
Tappahannock 3
Tucson 3
Totale 2.708
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 715
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 313
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 227
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 221
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia. 179
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 162
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 155
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 138
Targeting metabolism and survival in chronic lymphocytic leukemia and richter syndrome cells by a novel NF-κB inhibitor 137
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 119
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 119
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. 115
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells 111
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA 109
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 108
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 94
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death 92
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 91
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 89
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes. 84
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 83
The PD-1/PD-L1 Axis Contributes to T Cell Dysfunction in Chronic Lymphocytic Leukemia 82
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. 71
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 71
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 70
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 70
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 70
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. 68
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. 66
CD38 signals up-regulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells. 63
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. 59
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options. 56
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 54
Novel richter syndrome xenograft models to study genetic architecture, biology, and therapy responses 49
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia 43
HPLC-based assay to monitor extracellular nucleotide/nucleoside metabolism in human chronic lymphocytic leukemia cells 41
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia 39
Totale 4.433
Categoria #
all - tutte 12.102
article - articoli 0
book - libri 0
conference - conferenze 3.282
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020436 0 0 0 60 29 77 49 40 34 78 41 28
2020/2021555 41 48 20 24 85 23 49 31 98 54 35 47
2021/2022666 42 27 30 62 18 87 47 22 20 70 154 87
2022/2023837 94 106 25 100 61 196 45 39 94 26 25 26
2023/2024510 60 75 33 16 47 73 11 80 12 20 31 52
2024/2025182 22 71 50 39 0 0 0 0 0 0 0 0
Totale 4.433